✦ LIBER ✦

Potential for low dose rate neutron brachytherapy for pelvic tumors

✍ Scribed by Y. Maruyama; J. Yoneda; J.R. Van Nagell

Publisher: Elsevier Science
Year: 1978
Tongue: English
Weight: 85 KB
Volume: 4
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(78)90634-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A tumor/normal tissue advantage for low

A tumor/normal tissue advantage for low dose rate neutron brachytherapy

✍ Yosh Maruyama; Jose M. Feola; J.Lawrence Beach 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 811 KB

Low dose rate versus high dose rate intr

Low dose rate versus high dose rate intraluminal brachytherapy for malignant endobronchial tumors

✍ Theodore C.M. Lo; Lyubov Girshovich; Glenn A. Healey; John F. Beamis Jr.; David 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Fractionated high-dose rate brachytherap

Fractionated high-dose rate brachytherapy for stereotactic treatment of brain tumors

✍ B. Berner; W. Grant III; S. Woo; E.B. Butler 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Current controversies in high-dose-rate

Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer

✍ Alexandra J. Stewart; Akila N. Viswanathan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

High-dose-rate versus low-dose-rate intr

High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix

✍ Karen K. Fu; Theodore L. Phillips 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 710 KB

Intraoperative high-dose-rate brachyther

Intraoperative high-dose-rate brachytherapy for pediatric solid tumors: a 10-year experience

✍ Karyn A Goodman; Suzanne L Wolden; Michael P LaQuaglia; Kaled Alektiar; David D' 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Purpose: To evaluate the efficacy and toxicity of intraoperative high-dose-rate brachytherapy (IOHDR) in the management of pediatric solid tumors. ## Methods and Materials: The records of 66 pediatric patients who underwent IOHDR for a solid tumor from February 1993 through December 2002 were ret